This Research Article [1] reports the sequencing of “U87MG” cells, which were acquired from ATCC. It has come to the authors’ attention that recent work from Allen et al. reveals that the U87 cell line used in this study is distinct from the original U87MG cell line [2]. Additional analyses by Allen et al. indicate that the cell line presented in the work is of (or likely of) glioblastoma cell origin. The conclusions in the manuscript remain unaltered.
“U87MG” is incorrect in the title, and in all other instances in the text. In all of these cases, the cell line referred to as “U87MG” should be called “U87(ATCC)”. The correct title is: U87(ATCC) Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line. The correct citation is: Clark MJ, Homer N, O'Connor BD, Chen Z, Eskin A, Lee H, et al. (2010) U87(ATCC) Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line. PLoS Genet 6(1): e1000832. doi:10.1371/journal.pgen.1000832.
References
- 1. Clark MJ, Homer N, O'Connor BD, Chen Z, Eskin A, Lee H, et al. (2010) U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line. PLoS Genet 6(1): e1000832. pmid:20126413
- 2. Allen M, Bjerke M, Edlund H, Nelander S, Westermark B. (2016) Origin of the U87MG glioma cell line: Good news and bad news. Science translational medicine. 2016;(8): 354: 354re3. pmid:27582061
Citation: Clark MJ, Homer N, O'Connor BD, Chen Z, Eskin A, Lee H, et al. (2018) Correction: U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line. PLoS Genet 14(5): e1007392. https://doi.org/10.1371/journal.pgen.1007392
Published: May 16, 2018
Copyright: © 2018 Clark et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.